Physician profile
Amine Nasri
NPI 1467171124
$4,260.45
in general payments reported to CMS, 2019-2025
14 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $662 · 2023: $2,806 · 2024: $623 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,076 · Travel and Lodging: $1,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,076.08 |
| Travel and Lodging | $1,522.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,345.14 | 2022-2024 | Corevalve Evolut R, Onyx Frontier |
| Edwards Lifesciences Corporation | $862.15 | 2023 | |
| Boston Scientific Corporation | $699.12 | 2023-2024 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon |
| Shockwave Medical, INC | $276.21 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $273.71 | 2023 | Impella |
| Penumbra, INC. | $169.81 | 2025 | Indigo System |
| Cardiovascular Systems INC. | $148.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $138.01 | 2024 | Xarelto |
| Abbott Laboratories | $121.55 | 2022-2024 | Xience Skypoint |
| Ge Healthcare | $100.21 | 2022 | |
| Chiesi USA, INC. | $79.02 | 2022 | |
| Pfizer INC. | $18.78 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $15.22 | 2024 | Farxiga |
| Terumo Medical Corporation | $13.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amine Nasri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.